The Nanobodies Market Is Driven By Growing Preference For Targeted Therapy Nanobodies are engineered antibody fragments derived from heavy-chain antibodies which are naturally found only in camelids. These antibody fragments consist of a single domain with high specificity and affinity to target antigens. Nanobodies feature small size of only 15 kDa, high stability, solubility and specificity allowing targeted delivery of therapeutics to desired disease site or...
0 Shares
1281 Views
0 Reviews